Orthopedic imaging relies on X-ray, MRI and CT to diagnose disorders and injuries affecting the bones, muscles, ligaments, tendons, cartilage, and spine. Orthopedists also use these test results to create an effective treatment plan.
Genicular artery embolization targets synovial blood vessel abnormalities believed to cause painful inflammation that contributes to the severe discomfort most patients experience with OA.
The goal of the study is to obtain quantitative data on how daily training and competing affect players’ musculoskeletal health. The information will be used to inform training, rest and recovery periods.
Although gadolinium-based contrast agents are largely considered safe and are routinely used for MRI exams, experts suggest that providers should still utilize GBCAs sparingly for musculoskeletal studies.
Several mainstream media outlets recently cast a bright spotlight upon the well-being of athletes who are returning to active rosters following injuries, causing many spectators to question the people in charge of making return-to-play decisions.
The use of NSAIDS such as ibuprofen and naproxen might not have the desired effect patients are seeking when it comes to joint pain, according to new findings to be presented at RSNA 2022.
An artificial intelligence system that is currently commercially available for use in adults could also have applications in a pediatric population, according to a new study in Pediatric Radiology.
Experts compared the cortical thickness of three bones—the radius, tibia and second metatarsal—of 200 volunteers who had undergone prior bone mineral density measurements to evaluate the ultrasound method’s accuracy.
The software was put to the test on nearly 5,000 trauma radiographs, assessing for the presence of fractures, dislocations, elbow effusions and focal bone lesions. In some cases, it outperformed radiologists by as many as 82 points.
Female authorship in musculoskeletal radiology research has seen a steady climb over the last two decades—a positive trend that is indicative of progress in a field where leadership is largely dominated by males.
The newly approved PET radiotracer is expected to improve patient care significantly. “We have been able to reach the pinnacle of myocardial perfusion imaging with flurpiridaz," one expert said.
GE HealthCare's flurpiridaz, the PET radiotracer that recently received FDA approval, offers several key benefits over SPECT. Jamshid Maddahi, MD, discussed the details in an exclusive interview.
Ultrafast MCE could go on to become a go-to treatment option for obstructive coronary artery disease, according to the authors of a new first-in-human clinical study.